Maggie L. Shaw


Superior T1D Control Seen With HCL Systems vs SAP Therapy in Older Adults

May 15, 2022

Type 1 diabetes (T1D) can be especially difficult to manage in older adults, so this new multinational review compared the safety and effectiveness of a hybrid closed-loop (HCL) system and sensor-augmented pump (SAP) therapy.

Dr Debra Patt Addresses the Importance of Cancer Screening Awareness, Strong Health Care Infrastructure

May 11, 2022

Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, discusses how community oncology practices have heightened their outreach efforts to entice patients back in for cancer screenings and the importance of thinking outside the box to overcome staffing shortages in the oncology space.

HCL Systems Convey Superior Glucose Outcomes vs Other Diabetes Technologies

May 11, 2022

This new study among a patient population living with type 1 diabetes compared their outcomes according to their type of insulin pump therapy: sensor-augmented pump, predictive low-glucose suspend, and hybrid closed-loop (HCL).

Remote Monitoring Not Successful at Reducing Death, Readmission From HF

May 09, 2022

In this study, investigators from Pennsylvania and New York evaluated outcomes among patients following their hospitalization for heart failure (HF) who did or did not participate in a remote monitoring program that included financial incentives for adherence.

Dr Anna Marzec-Bogusławska: Advocacy Helped to Overcome Fear, Stigma of HIV/AIDS in Poland

May 09, 2022

Anna Marzec-Bogusławska, MD, MPH, managing director, National AIDS Center, Warsaw, Poland, discusses how stigma and discrimination permeated the beginning of the HIV/AIDS epidemic the country in the early 1980s and ways that advocates stepped up to overcome peoples’ fears.

Cardiac Rehab Linked to Improved Mortality Among Patients With HFrEF

May 06, 2022

In this study, outcomes were investigated among a cohort of patients with heart failure with reduced ejection fraction (HFrEF) who participated in a cardiac rehabilitation program post hospital discharge after they survived acute onset of HFrEF.

Dr Roxana Siles: Blinded Trials Are Important When Evaluating Chronic Cough Treatment

May 06, 2022

Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the placebo effect seen in clinical trials of chronic cough treatment.